#Axovia
LightNews LightNews
newsen.bsky.social
Viralgen and Axovia Join Forces for Gene Therapy Development for Retinal Dystrophy#Spain#San_Sebastián#Viralgen#Axovia#BBS
Viralgen and Axovia Join Forces for Gene Therapy Development for Retinal Dystrophy
Viralgen and Axovia are collaborating to manufacture an investigational gene therapy targeting retinal dystrophy in Bardet-Biedl Syndrome patients.
third-news.com
January 22, 2025 at 3:02 PM
l2plabs.bsky.social
Viralgen and Axovia partner to manufacture an investigational gene therapy for retinal dystrophy in Bardet-Biedl Syndrome (BBS) patients
Collaborative effort will bring hope to BBS patients suffering from retinal degeneration through this investigational gene therapy. SAN SEBASTIÁN, Spain and LONDON, Jan. 22, 2025 /PRNewswire/ -- Viralgen and Axovia Therapeutics are joining forces to…
dlvr.it
January 22, 2025 at 2:20 PM
drtimos.bsky.social
Thoughts on this? >> Axovia Therapeutics Unveils New Preclinical Data for -
GlobeNewswire >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #competitivemarketing #biotech #healthcare
Axovia Therapeutics Unveils New Preclinical Data for - GlobeNewswire
Axovia Therapeutics Unveils New Preclinical Data for  GlobeNewswire
dlvr.it
May 15, 2025 at 12:01 PM
drtimos.bsky.social
Thoughts on this? >> Axovia Therapeutics Presents New Preclinical Data for
AXV-101 for the Treatment of Blindness Associated with BBS
Mutations at ASGCT - The Manila… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #biotech #healthcare #pharma
Axovia Therapeutics Presents New Preclinical Data for AXV-101 for the Treatment of Blindness Associated with BBS Mutations at ASGCT - The Manila Times
Axovia Therapeutics Presents New Preclinical Data for AXV-101 for the Treatment of Blindness Associated with BBS Mutations at ASGCT  The Manila Times
dlvr.it
May 13, 2025 at 11:30 AM
cengem.bsky.social
When the work of centre members has an impact on people. News from Dr Victor Hernandez and Axovia Therapeutics. #gentherapy #cengem

axoviatherapeutics.com/axovia-thera...
Axovia Therapeutics Presents New Preclinical Data for AXV-101 for the Treatment of Blindness Associated with BBS Mutations at ASGCT - Axovia Therapeutics
London, UK – May 13, 2025 – Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, announced the presentation of new preclinical...
axoviatherapeutics.com
May 13, 2025 at 3:06 PM